| Announce Date | 02/05/2026 |
| EPS Normalized Actual | $2.96 (Beat by $0.14) |
| EPS GAAP Actual | $2.96 (Beat by $0.14) |
| Revenue Actual | $2.0483B |
| Revenue Surprise | Beat by $2048.3M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $2.46 |
| EPS GAAP Estimate | $2.46 |
| Revenue Estimate | $2.242633358B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 12.17745 | 6.96 | 11.96485 | 12.33536 | 1 |
| Dec 2027 | 13.28208 | 6.38 | 12.92643 | 13.48993 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 1.68 | -1.24 | 2.0483B | -1.19% | -566.95M |
| FQ3 2025 (Sep 2025) | 1.62 | -1.62333 | 2.00384B | -4.19% | -601M |
| FQ2 2025 (Jun 2025) | 1.48 | -1.46 | 2.09148B | -3.36% | -500.87M |
| FQ1 2025 (Mar 2025) | 0.24 | -2.175 | 2.10356B | -13.12% | -440.8M |
| FQ4 2024 (Dec 2024) | 1.15 | 1.15 | 2.07266B | -7.88% | 2072.66M |
| FQ3 2024 (Sep 2024) | 1.81 | 1.81 | 2.08789B | -8.54% | 2087.89M |
| FQ2 2024 (Jun 2024) | 2.69 | 2.69 | 2.16166B | -8.69% | 2161.66M |
| FQ1 2024 (Mar 2024) | 2.06 | 2.06 | 2.37948B | 2.33% | 2379.48M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
2.46
Consensus Revenue Estimates
2.242633358B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 3.05 | -- | 2.96443 | 3.13971 | 1 |
| FQ3 2027 (Sep 2027) | 2.66 | -- | 2.58537 | 2.73824 | 1 |
| FQ2 2027 (Jun 2027) | 2.52 | -- | 2.4493 | 2.59412 | 1 |
| FQ1 2027 (Mar 2027) | 1.84 | -- | 1.78838 | 1.89412 | 1 |
| FQ4 2026 (Dec 2026) | 3.46 | 51.45 | 3.20697 | 3.72226 | 1 |
| FQ3 2026 (Sep 2026) | 3.05 | 46.89 | 2.82696 | 3.28118 | 1 |
| FQ2 2026 (Jun 2026) | 3.02 | 50.99 | 2.79915 | 3.24891 | 1 |
| FQ1 2026 (Mar 2026) | 2.46 | 90.24 | 2.2801 | 2.64646 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 2.17B | -- | 2.12B | 2.21B | 1 |
| FQ3 2027 (Sep 2027) | 2.11B | -- | 2.06B | 2.15B | 1 |
| FQ2 2027 (Jun 2027) | 2.2B | -- | 2.15B | 2.25B | 1 |
| FQ1 2027 (Mar 2027) | 2.2B | -- | 2.15B | 2.25B | 1 |
| FQ4 2026 (Dec 2026) | 2.32B | 11.87 | 2.19B | 2.46B | 1 |
| FQ3 2026 (Sep 2026) | 2.3B | 12.75 | 2.17B | 2.43B | 1 |
| FQ2 2026 (Jun 2026) | 2.27B | 7.84 | 2.14B | 2.4B | 1 |
| FQ1 2026 (Mar 2026) | 2.24B | 6.2 | 2.12B | 2.37B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
4
Revenue # of Misses
4
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 2.92 | 1.68 | -1.24 | -73.81% |
| FQ3 2025 (Sep 2025) | 3.24333 | 1.62 | -1.62333 | -100.21% |
| FQ2 2025 (Jun 2025) | 2.94 | 1.48 | -1.46 | -98.65% |
| FQ1 2025 (Mar 2025) | 2.415 | 0.24 | -2.175 | -906.25% |
| FQ4 2024 (Dec 2024) | 1.15 | 1.15 | 100% | |
| FQ3 2024 (Sep 2024) | 1.81 | 1.81 | 100% | |
| FQ2 2024 (Jun 2024) | 2.69 | 2.69 | 100% | |
| FQ1 2024 (Mar 2024) | 2.06 | 2.06 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $2.62B | $2.05B | $-566.95M | -27.68% |
| FQ3 2025 (Sep 2025) | $2.6B | $2B | $-601M | -29.99% |
| FQ2 2025 (Jun 2025) | $2.59B | $2.09B | $-500.87M | -23.95% |
| FQ1 2025 (Mar 2025) | $2.54B | $2.1B | $-440.8M | -20.95% |
| FQ4 2024 (Dec 2024) | $0B | $2.07B | $2072.66M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $2.09B | $2087.89M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $2.16B | $2161.66M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $2.38B | $2379.48M | 100% |